| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_114e4423ec77cbc8dab9d0a98909704e |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-695
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F7-0816
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P33-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F7-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-695 |
| filingDate |
2017-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2020-02-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_66f60be10f37101348a2402cd69477a2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_528f0312532f76fdd28c82b81cbc1f8d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b5db55a1de649e255fd3f3fe56c45469
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_26cf40eaf4b48614aef6c4e7659eb0e6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0d98224611e0ef3a9139ebd480ece95d |
| publicationDate |
2020-02-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-10550135-B2 |
| titleOfInvention |
Silicon incorporated quinolines with anti-malarial and anti-toxoplasmosis activity |
| abstract |
The present invention discloses a silicon incorporated quinoline of formula (I) wherein, X, Y, A, R 1 and R 2 are as described. The present invention further discloses a process for the preparation of silicon incorporated quinolines of formula I; a pharmaceutical composition comprising silicon incorporated quinolines of formula (I) or pharmaceutically acceptable salt thereof. The present invention also discloses a method for treating diseases caused by Plasmodium falciparum or other coccidian parasites using the silicon incorporated quinolines of formula I or pharmaceutically acceptable salt thereof. |
| priorityDate |
2016-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |